Title: The Center for Wound Healing, Inc'
1The Center for Wound Healing, Inc. (Symbol
CFWH.OB)
Andrew G. Barnett, Chief Executive Officer
Investor Presentation June, 2009
2Safe Harbor Statement
- This presentation contains forward-looking
statements within the meaning of the Private
Securities Litigation Reform Act of 1995 that
involve significant risks and uncertainties.
Such forward-looking statements involve a number
of known and unknown risks, uncertainties and
other factors which may cause the actual results,
performance or achievements of the Company to be
materially different from any future results,
performance or achievements expressed or implied
by such forward-looking statements. Such factors
include, but are not limited to, the risks of
uncertainty of patent protection, the impact of
supply and manufacturing constraints or
difficulties, product market acceptance, possible
technological obsolescence, increased
competition, customer concentration and other
risks detailed in the Companys filings with the
Securities and Exchange Commission. - The words believe, demonstrate, intend,
expect, estimate, anticipate, likely, and
similar expressions identify forward-looking
statements. Readers are cautioned not to place
undue reliance on those forward-looking
statements, which speak only as of the date the
statement was made. The Company is under no
obligation to provide any updates to any
information contained in this presentation.
Page 2
3The Center for Wound Healing, Inc.
- CFWH develops and manages hospital-based wound
care centers that provide traditional wound care
and hyperbaric (HBO) treatments to outpatients
on an outsourced basis. - Our centers utilize advanced wound healing
technologies, including HBO, and a
multi-disciplinary team approach to heal chronic
and acute non-healing wounds such as diabetic,
venous stasis, pressure, trauma and ischemic
wounds. - As an outpatient unit, the CFWH staff works
closely with each patients primary physician to
treat and heal the patients wound in a cost
effective and timely manner.
4Investment Highlights
- Large market driven by diabetes treatment
- Companys patient population Diabetics comprise
80 and are 60 years of age the fastest
growing medical demographic - Real upside with Medicare expansion to millions
uninsured - Financial turnaround achieved 2007 2008
- Gross margin up 900 basis points
- EBITDA from 180,000 to 8.6 million
- Growth continues through 2009YTD
- Compelling value proposition at all levels
- Improved outcomes for patients
- Turnkey approach that generates significant cash
flow for hospitals and substantial income for
doctors - Cost reduction throughout the healthcare system
- Highly scalable, profitable business model with
significant operating leverage - Company centers expected to double in three years
Page 4
5Large Market Opportunity
- Large and growing hospital opportunity
- 700 hospitals in New England, Mid-Atlantic
states - 4,000 hospitals in U.S. that can support HBO
- Market strata
- Virgin hospitals that dont have dedicated
wound healing centers - Hospitals with wound healing but not HBO
- Hospitals that offer both and self-manage
- Hospitals under contract with competitors
- Growing diabetic population
- Podiatrists, vascular surgeons, plastic surgeons,
post-radiation oncologists, oral surgeons, and
head and neck surgeons are our primary referral
sources
Page 5
6Focus on Diabetes
- Chronic wounds occur in over two percent of the
general population with medical treatment costs
exceeding 2 billion - Diabetes affects 24 million people in US
incidence is growing at approximately eight
percent per year -
- Diabetic foot ulcers, frequently treated by HBO,
affect over 800,000 people per year - Diabetics account for 80 of our portfolio
patient population and the average age is 60 - We serve the fastest growing medical demographic
in the United States
Page 6
7Successful Turnaround 2007 - 2008
- January 2007 Scenario
- No financial or accounting systems
- Investment spending out-of-control lt30 days cash
on hand - No working capital management AR and AP
- Toxic sub-debt
- Year Ended June 30, 2008 (comparisons w/07)
- Sales of 26.4 million, up 33
- Operating income 3.1 million v. 7 million loss
- Gross margin 50.1 v. 41.3
- EBITDA 8.6 million v. 180,000
8Benefits Multiple Levels of Our Healthcare System
- Patients
- Safe, effective treatment that returns patients
to more productive lives - Hospitals
- Generates substantial free cash flow in excess of
450,000 per year at program maturity, within
year one - Ancillary services revenue, reduced LOS and
improved margins, long-term and profitable
patient relationships within catchment area - Significant income opportunity for doctors
- Healthcare system
- Substantially reduced costs
- Improved hospital profitability from existing
businesses -
Page 8
9Hyperbaric Oxygen Therapy
- Simple, non-invasive and painless treatment
enhances the bodys natural healing and
strengthens the immune system, resulting in more
rapid and complete healing for patients - The patient rests in a transparent airtight
chamber with 100 oxygen at 2-3x sea level
atmospheric pressure - Creates a 10- to 15- fold increase in plasma
oxygen concentration with a resultant increase in
tissue oxygenation - 83 of patients undergoing HBO therapy in our
centers heal
10Turnkey Operation for Hospitals
- We manage the build out of facility, purchase the
furniture, and all equipment, including the
hyperbaric chambers, and hire and manage staff - We provide advanced wound care practice
guidelines, training, policies and procedures,
and deploy WoundDocs, our state-of-the-art,
web-based electronic medical records application - We manage the program and control all
administrative functions of the center - Our financial relationship is with the hospital,
not with insurance companies. We assist the
hospital with the billing process, collections
and medical appeals, if necessary - We market the program to the hospitals referral
base
Page 10
11Cost Benefits for Healthcare System
- Reduced inpatient stays, reduction in hospital
time and costs, improved hospital margins - Decrease in amputation rates
- Huge cost savings between amputation and HBO
- Faster healing 83 of our HBO patients heal
- Average of 35 HBO treatments/patient v. national
Medicare average of 45 treatments/patient - Compelling economics for hospitals, physicians
and both government and commercial insurers - Patients return to more productive lives without
taxing the healthcare system
12Retail Model Improves Performance
- New centers are operational within four months of
contract signing and reach maturity within one
year - Key metrics
- Inventory turn a/k/a chamber utilization dives
per center/day currently 6.4, up from 5.3 in
January 08 target 6.5 by July - Average current revenue/reimbursement per dive of
495 - Direct labor costs maintaining flat labor cost
at three to seven dives per center/day - Patient population is 42 Medicare
- Significant operating leverage
- Increasing portfolio dives from 6.0 to 6.5 per
day yields annualized 2.1 million revenue, 1.6
million EBITDA
13Improved Center Management
- Regional Management Structure
- Hub-and-spoke portfolio management
- Measurement metrics similar to retail store or
franchise models volume, direct costs, four-wall
contribution - Repopulated most center operations management
- Maximize gross margin dollars
- State-of-the-art Business Processes and Systems
- WoundDocs, our HIPAA-compliant web-based EMR
application being rolled-out to portfolio and
will be complete EOM May - Great Plains financial reporting application
suite - Revamped and Focused Marketing Efforts
- Consistent educational outreach on HBO and wound
care - Clinical Liaison Specialists
14Center Structure and Economics
- A typical comprehensive wound care center offers
advanced wound care and HBO therapies - Staffing includes
- Program Manager
- Registered Nurse
- HBO Technicians (2)
- Annual staffing costs of approximately 300
thousand - CFWH investment includes
- Buildout of 240 thousand
- Two HBO chambers at 100 thousand each
- Other FFE of 30 thousand
- 2,300 square feet provided by the hospital at no
charge - Expected HBO treatment rollout begins at three
dives and reaches maturity within six months
seven dives/day
15Center Structure and Economics
- Costs and returns to hospital
- Up to 25 of the buildout, approximately 50,000
- Space provided to CFWH at no charge
- Minor supplies costs, about 8/patient
- An average of 450,000 cash flow per year
- Doctor income of 250,000 per year
- CFWH four wall contribution a/k/a gross margin
- Breakeven at month one (three dives/day)
- 40.0 month four
- 47.5 month 12 and forward
- At maturity and for the life of the contract, a
center should generate annual revenue and
contribution of 950,000 and 450,000,
respectively
16Recent Operating Progress
- Center openings
- Monmouth Medical Center, Monmouth, NJ (August 08)
- Pottstown Medical Center, Pottstown, PA
(December 08) - Jameson Medical Center, New Castle, PA (January
09) - Princeton University Hospital, Princeton, NJ
(April 09) - Strong sales target pipeline
- Opportunities to grow beyond the pipeline, i.e.,
acquisitions, have been identified - Rendered 49,000 treatments in CY08 v. 42,000
CY07 wound care volume is up 20 - Approximately 10 of wound care patients are HBO
candidates
Page 16
17Current Facilities
18Strategic Growth Initiatives
- Center openings
- Expect up to three centers in calendar 2009
- 10 centers in fiscal 2010 15 centers per fiscal
year, 2011 - 2012 - Bolster footprint within current markets of New
England and mid-Atlantic states - Expand geographic base to regions identified by
management western Pennsylvania, Illinois,
Kentucky, Ohio, Michigan, Alabama - Green field opportunities
- Hospitals with wound care but without HBO
- Acquire existing programs
19Selected Financials
20Selected Financials
- Three Months Ended March 31, 2009
- Sales of 6.9 million, up six percent compared
with the prior years three month period - Operating income of 455,000
- Gross margin of 47.1 for the quarter
- EBITDA of 1.8 million
- Nine Months Ended March 31, 2009
- Sales of 21.5 million, up 14 compared with the
prior period - Operating Income of 1,356,000
- Gross margin was 48.6
- EBITDA of 6.3 million
Page 20
21What is EBITDA and Why is it Important?
- Earnings Before Interest, Taxes, Depreciation and
Amortization - Critical measure of operating results because it
excludes capital structure costs and non-cash
items. - For a company like ours, which has a complex
capital structure that uses two forms of debt,
including debt with warrants, EBITDA is the only
way to measure true operating performance. - Demonstrates a companys ability to service its
capital structure costs and investment spending
capabilities
Page 21
22CFWH Net Loss and EBITDA
Page 22
23The Need and Ability to Generate Cash
Page 23
24The Ultimate Measure of a Companys
CapabilitiesThe Ability to Generate Free Cash
Flow
Page 24
25Balance Sheet and Liquidityat March 31 09
- Current Ratio was 21
- 8.9MM of working capital
- Senior bank facility of 8MM, outstanding were
3.7MM, the lowest since January 07 - We expect to generate close to 5MM of cash from
operations for FY09 and approach 7MM next year - We have more than enough liquidity to fund all
operating, investment spending and balance sheet
obligations in accordance with our business plan
26Investment Highlights
- Large market driven by diabetes treatment and an
aging population the fastest growing medical
demographic - Potential additional upside with Medicare
expansion to million of the uninsured - Financial turnaround achieved 2007 2008
- Gross margin up 900 basis points
- EBITDA from 180,000 to 8.6 million
- Compelling value proposition at all levels
- Improved outcomes for patients
- Turnkey operation for hospitals
- Significant generation of free cash flow to
hospitals and doctors - Cost reduction for healthcare system
- Highly scalable, profitable business model with
significant operating leverage - Number of centers expected to double in three
years
27The Center for Wound Healing, Inc. (Symbol
CFWH.OB)
Andrew G. Barnett Chief Executive Officer